OHR PHARMACEUTICAL INC's ticker is OHRP and the CUSIP is 67778H200. A total of 12 filers reported holding OHR PHARMACEUTICAL INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $46,000 | -6.1% | 536,322 | +100.0% | 0.00% | – |
| Q3 2018 | $49,000 | -5.8% | 268,161 | 0.0% | 0.00% | – |
| Q2 2018 | $52,000 | -10.3% | 268,161 | 0.0% | 0.00% | – |
| Q1 2018 | $58,000 | -77.4% | 268,161 | +93.6% | 0.00% | – |
| Q4 2017 | $257,000 | +138.0% | 138,492 | -8.4% | 0.00% | – |
| Q3 2017 | $108,000 | +12.5% | 151,120 | 0.0% | 0.00% | – |
| Q2 2017 | $96,000 | -24.4% | 151,120 | -1.6% | 0.00% | – |
| Q1 2017 | $127,000 | -44.5% | 153,509 | +0.2% | 0.00% | – |
| Q4 2016 | $229,000 | -47.0% | 153,185 | +0.1% | 0.00% | – |
| Q3 2016 | $432,000 | +3.3% | 152,969 | +0.0% | 0.00% | – |
| Q2 2016 | $418,000 | -14.7% | 152,915 | 0.0% | 0.00% | – |
| Q1 2016 | $490,000 | -45.7% | 152,915 | +3.9% | 0.00% | -100.0% |
| Q4 2015 | $903,000 | +120.2% | 147,121 | -1.1% | 0.00% | – |
| Q3 2015 | $410,000 | +44.4% | 148,741 | +31.4% | 0.00% | – |
| Q2 2015 | $284,000 | -13.7% | 113,182 | -12.7% | 0.00% | – |
| Q1 2015 | $329,000 | -65.0% | 129,658 | +15.1% | 0.00% | -100.0% |
| Q4 2014 | $939,000 | +16.9% | 112,632 | +1.6% | 0.00% | 0.0% |
| Q3 2014 | $803,000 | -23.7% | 110,894 | +0.1% | 0.00% | 0.0% |
| Q2 2014 | $1,053,000 | -6.2% | 110,780 | +34.2% | 0.00% | 0.0% |
| Q1 2014 | $1,123,000 | +424.8% | 82,561 | +202.7% | 0.00% | – |
| Q4 2013 | $214,000 | +41.7% | 27,278 | +46.5% | 0.00% | – |
| Q3 2013 | $151,000 | – | 18,623 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |